Equities

Theralase Technologies Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Theralase Technologies Inc

Actions
Health CareMedical Equipment and Services
  • Price (CAD)0.300
  • Today's Change0.005 / 1.69%
  • Shares traded4.00k
  • 1 Year change0.00%
  • Beta0.4762
Data delayed at least 15 minutes, as of Feb 13 2026 20:10 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Key statistics

On Friday, Theralase Technologies Inc (TLT:CVE) closed at 0.300, -16.67% below its 52-week high of 0.36, set on Jan 12, 2026.
52-week range
Today
0.145Dec 15 20250.36Jan 12 2026
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.300
High0.300
Low0.300
Bid0.300
Offer0.31
Previous close0.295
Average volume231.63k
Shares outstanding257.06m
Free float236.65m
P/E (TTM)--
Market cap77.12m CAD
EPS (TTM)-0.0174
CAD
Data delayed at least 15 minutes, as of Feb 13 2026 20:10 GMT.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.